Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2010 Mar 9.
Published in final edited form as: Mutat Res. 2008 Nov 27;662(1-2):84–87. doi: 10.1016/j.mrfmmm.2008.11.012

TREX2 Exonuclease Defective Cells Exhibit Double-Strand Breaks and Chromosomal Fragments but Not Robertsonian Translocations

Lavinia C Dumitrache 1, Lingchuan Hu 1, Paul Hasty 1
PMCID: PMC2677549  NIHMSID: NIHMS102268  PMID: 19094998

Abstract

TREX2 is a 3′→5′ exonuclease that binds to DNA and removes 3′ mismatched nucleotides. By an in vitro structure function analysis, we found a single amino acid change (H188A) completely ablates exonuclease activity and impairs DNA binding by about 60% while another change (R167A) impairs DNA binding by about 85% without impacting exonuclease activity. For a biological analysis, we generated trex2null cells by deleting the entire Trex2 coding sequences in mouse embryonic stem (ES) cells. We found Trex2 deletion caused high levels of Robertsonian translocations (RbTs) showing Trex2 is important for chromosomal maintenance. Here we evaluate the exonuclease and DNA binding domains by expressing in trex2null cells coding sequences for wild type human TREX2 (Trex2hTX2) or human TREX2 with the H188A change (Trex2H188A) or the R167A change (Trex2R167A). These cDNAs are positioned adjacent to the mouse Trex2 promoter by Cre-mediated knock-in. By observing metaphase spreads, we found Trex2H188A cells exhibited high levels of double-strand breaks (DSBs) and chromosomal fragments. Therefore, TREX2 may suppress spontaneous DSBs or exonuclease defective TREX2 may induce them in a dominate-negative manner. We also found Trex2hTX2, hTrex2H188A and hTrex2R167A cells did not exhibit RbTs. Thus, neither the exonuclease nor DNA binding domains suppress RbTs suggesting TREX2 possesses additional biochemical activities.

Keywords: TREX2, exonuclease, double-strand breaks, Robertsonian translocations, genomic stability

1. Introduction

The mammalian Three prime Repair Exonuclease (TREX) proteins, TREX1 and TREX2 are homologous to the proofreading exonuclease in bacterial DNA polymerases important for postreplication repair [14]. In vitro, both function as homodimers, bind to DNA and effectively remove 3′ mismatched sequences via their 3′→5′ exonuclease activity [5]. To better understand biological function, Trex1 was mutated in mice; however, surprisingly trex1/ mice did not show genomic instability as would be expected for defective postreplication repair but instead died from cardiomyopathy caused by inflammatory myocarditis [6]. This unexpected phenotype suggested that TREX1 is not directly involved in DNA repair despite its sequence homology to exonucleases and its exonuclease activity. To help explain this surprising phenotype, TREX1 was later shown to process cytosolic DNA that may arise from endogenous retroelements or aberrant replication intermediates [7,8]. Failure to do so leads to the accumulation of cytosolic DNA that ultimately induces a pathological autoimmune response designed to defend against viruses or a chromic DNA damage checkpoint. To support these findings, TREX1 mutations cause a variety of autoimmune disorders in humans [9,10]. In addition, TREX1 is apart of the Granzyme A mediated cell death pathway since it binds to the SET complex and degrades nuclear DNA in concert with the endonuclease NM23-H1 [11]. Thus, TREX1 performs several functions, but does not appear to be important for DNA repair while much less is known about TREX2 biological function.

To better understand TREX2 biological function, we generated trex2null mouse ES cells by deleting all the known Trex2 coding sequences via gene targeting [12]. We found trex2null cells exhibited high levels of Robertsonian translocations (RbTs). RbTs are chromosome rearrangements involving centric fusion of two acrocentric chromosomes to form a single metacentric chromosome that results from deletion of the p arms from both chromosomes [13,14]. RbTs may influence speciation [15,16] and may increase cancer risk [17], spontaneous abortions [18] and male infertility [19]. Thus, Trex2 maintains chromosomal integrity but we do not know if the exonuclease and DNA binding activities are important for suppressing RbTs.

TREX2 works as a homodimer to bind to DNA and remove 3′ mismatched sequences. Single amino acid mutations were made in TREX2 to separate DNA binding from exonuclease activity [2022]. The H188A alteration completely ablates exonuclease activity but also impairs DNA binding by about 60% while the R167A change impairs DNA binding by about 85% without diminishing exonuclease activity [21]. Therefore, these functions may be genetically separated, at least in part, yet the biological significance of these activities is not known.

Here we report the impact human wild type TREX2 and human TREX2 mutated in the exonuclease domain or DNA binding domain has on mouse ES cells. We find Trex2-deletion mildly increases the level of spontaneous chromosomal DSBs and fragments. This phenotype is rescued by expression of wild type human TREX2 [21] and TREX2 mutated in the DNA binding domain. However, expression of TREX2 mutated in the exonuclease domain resulted in a further increase in chromosomal breaks suggesting a dominant negative phenotype. Surprisingly, expression of wild type TREX2 and either mutant prohibited the formation of RbT’s, suggesting that TREX2 possesses functions other than DNA binding and exonuclease activity that are important for genomic stability.

2. Materials and Methods

2.1. Cell culture conditions

AB2.2 ES cells were maintained in M15 [high glucose DMEM supplemented with 15% fetal bovine serum, 100μM β-mercaptoethanol, 1 mM glutathione, 3 mg/ml penicillin, 5 mg/ml streptomycin, 1000 U/ml ESGRO (LIF)] and grown on plates with 2.5 × 106 γ-irradiated murine embryonic fibroblasts (mitotically inactive feeders) seeded on 0.1% gelatin coated plastic at least the day before and grown in 5% CO2 in a 37°C incubator at atmospheric O2.

2.2. Knock-in into ES cells

To integrate the human cDNA next to the mouse Trex2 promoter, a Cre-mediated knock-in (CMKI) plasmid [23] with the short isoform of human cDNA [21] was transfected into trex2null-2 cells that had been previously deleted for the 5′ half of the HPRT minigene [12]. 5 X 106 cells were co-electroporated with 20μg of CMKI plasmid and 10μg of a Cre-recombinase expression vector (pPGKcrepA) in a total of 800μl DPBS (Dulbecco’s Phosphate Buffered Saline) using a Bio-Rad Gene Pulsar at 230V, 500μF. Then 200μl of the electroporation was seeded onto a 10cm feeder plate (primary embryonic fibroblasts mutated for HPRT). After 48 hours of transfection, a final concentration of 1 X HAT (1 mM sodium hypoxanthine, 4 μM aminopterin, and 160 μM thymindine) was added to the media. Eight-ten colonies were picked after 7–10 days of selection and expanded in HAT selection media to eliminate HPRT negative cells that survive by cross-feeding. These colonies were replica plated, and then one plate was frozen while the other plate was used to isolate DNA [24] for screening knock-in clones by genomic PCR.

2.3. Verification of knock-in

PCR verified knock-in by using Cre1 and hTX2Rev primers. PCR conditions: The forward primer (Cre 1: 5′ CCATGAGTCCTCTTTAAAGTG 3′) and reverse primer (hTX2Rev: 5′ CTGCAGCGTCCGCACCACG 3′) were used under these conditions: one cycle of 98°C 5 minutes followed by 35 cycles of 98 °C 1 minute’, 63.5 °C 1 minute, 72 °C 1 minute 40 seconds followed by one cycle of 72 °C 10 minutes).

RT-PCR also verified knock-in by using primers specific to human TREX2 (hTX2For, hTX2Rev). PCR was performed on RNA with and without reverse transcriptase (+/−) to ensure there is no DNA contamination. RT-PCR conditions: The forward primer (hTX2For: 5′ AAA AGA ATT CCC GCC ACC ATG TCC GAG GCACCCCGGGC 3′) and reverse primer (hTX2Rev2: 5′ CTGCAGCGTCCGCACCACG 3′) were used under these conditions: one cycle of 98 °C 5 minutes followed by 35 cycles of 98C 1 minute, 65°C 1 minute, 72 °C 25 seconds followed by one cycle of 72 °C 10 minutes).

2.4. Three-color FISH (Fluorescence in situ hybridization)

Treat cells with 10mgs colcemid for 4 hours then trypsinized cells. Slide preparation: Spin cells (1000 rpm), 10′ wash cells x2 in PBS (all PBS washes are pH 7.4 unless otherwise noted.). Resuspended pellet in 300mL 75mM KCl, dropwise, flicking tube. Incubate 37°C water bath, 15′. Add 300mL methanol/acetic acid (3:1 fixative), dropwise, flicking tube, spin 3000 rpm, 30″. Wash cells in 300mL 3:1 fixative, dropwise, flicking tube, spin @ 3000 rpm, 30″; rpt wash. Hybridization: Place slides in 70mM NaOH, 2′. Wash in PBS pH 8.5, 10 dips. Incubate 37 degrees, 5′ in the dark, in 500 μl/slide of 0.25mg/mL major satellite repeat (CY-3 5′ TGG AAT ATG GCG AGA AAA CTG AAA ATC ATG GAA AAT GAG A 3′) and telomeric [6-FAM 5′ (CCCTAA)7 3′] probes wash in PBS, 10 dips, coverslip in DAPI.

3. Results and Discussion

Here we evaluate the TREX2 exonuclease and DNA binding domains by introducing human TREX2 coding sequences adjacent to the mouse Trex2 promoter in trex2null cells. Previously we generated trex2null AB2.2 ES cells (Fig. 1A) by replacing the entire known mouse Trex2 coding sequence [12] with a floxed hypoxanthine phosphoribosyltransferase (HPRT) minigene [25], referred to as miniHPRT. MiniHPRT is selected for expression in HAT (hypoxanthine, aminopterin, thymidine) or for absence of expression in 6-TG (6-thioguanine) and is composed of a phosphoglycerol kinase (PGK) promoter with an intron that separates exons 1–2 from exons 3–8. We modified miniHPRT by placing a right element (RE) mutant loxP [26] 5′ to the promoter and another RE mutant loxP in the intron [27]. After gene targeting, the 5′ half of miniHPRT was removed upon Cre-mediated recombination leaving behind a RE mutant loxP and the 3′ half of the minigene (Fig. 1B). These cells are now called trex2null-2. The short isoform of wild type human TREX2 cDNA [21] was targeted adjacent to the endogenous mouse TREX2 promoter by a recently described protocol called Cre-mediated knock-in [23]. Three different cDNAs were used to generate ES cells with wild type human TREX2 (Trex2hTX2) or with the H188A mutation (Trex2H188A) or the R167A mutation (Trex2R167A) [21]. These cDNA sequences were cloned into a Cre-mediated knock-in (CMKI) plasmid that contains the 5′ half of miniHPRT. These CMKIs were cotransfected with a Cre recombinase expression plasmid into trex2null-2 cells. Knock-in clones may be isolated in HAT selection media since they regenerate miniHPRT (Fig. 1C). Multiple clones of each were isolated and confirmed by PCR and RT-PCR (Fig. 1D). Thus, we have multiple clones of mouse ES cells that express either wild type human TREX2 or human TREX2 with a single amino acid change (either H188A or R167A) using the mouse Trex2 promoter.

Fig. 1.

Fig. 1

Knock-in of human TREX2 cDNA variants. (A) The HPRT minigene, expressed by the PGK promoter [25,29] is used for selection and contains exons 1 and 2 (box labeled 1&2), exons 3–8 + polyadenylation sequences (box labeled 3–8) separated by an intron (straight line). Select for minigene expression in HAT. A RE mutant loxP (black arrow head) [26] is 5′ to PGK and another RE mutant loxP is in the intron. An FRT (open arrow) is located 3′ to miniHPRT. Upon targeting the entire known mouse TREX2 open reading frame (rectangle) is deleted as previously described [12]; this sequence corresponds to the human short isoform [21]. PRO, mouse Trex2 promoter. (B) Removal of the 5′ half of miniHPRT by Cre recombination as previously described [12]. (C) Knock-in of the short isoform of human TREX2 cDNA (hTX2). A Cre-mediated knock-in plasmid is cotransfected along with a Cre-expression plasmid. The knock-in vector contains the 5′ half of miniHPRT, a left element (LE) mutant loxP (Grey arrow head) and the cDNA with bovine growth hormone polyadenylation sequences as previously described [23]. Cells are selected in HAT for restoration of miniHPRT. The knock-in corrects miniHPRT, generates an RE LE mutant loxP (left, black grey arrow), a wild type loxP (right, grey black arrow) and places the cDNA adjacent to the mouse TREX2 promoter. (D) Verification of knock-in. Due to the stringent selection, all HAT resistant clones are positive for knock-in as verified by PCR (left) using Cre1 and hTX2Rev primers. Ku80 (80) was used as a loading control for PCR as previously described [12]. In addition, human TREX2 expression is confirmed by RT-PCR (right) using primers specific to human TREX2 (hTX2For, hTX2Rev). Note the primers are specific for human TREX2 since mouse Trex2 is not amplified in the AB2.2 control. PCR was performed on RNA with and without reverse transcriptase (+/−) to ensure there is no DNA contamination. Rad51 (51) was used as loading control for RT-PCR as previously described [12].

We observed metaphase spreads derived from two clones of each knock-in by three-color FISH (Table 1, Fig. 2). These cells were stained with a telomeric probe (green), a major satellite repeat (MSR) probe in the pericentromere (red) and DAPI (blue) [28]. We found metaphase spreads derived from trex2null-2 cells exhibited a mild increase in chromosomal DSBs and fragments compared to AB2.2 clones (p=0.0023, Fisher’s exact test) while metaphase spreads derived from Trex2H188A cells exhibit much higher levels of DSBs and fragments compared to AB2.2 (p>0.0001), trex2hTX2 (p>0.0001) and trex2null (p>0.0001) cells. These breaks are often located in or next to the pericentromere, a highly repetitive region that is composed of 6–8 Mb of tandem MSRs that undergo dynamic regulation [28]. However, Trex2R167A cells exhibited the same levels of DSBs and fragments as compared to AB2.2 (p=1.0) and Trex2hTX2 (p=1.0) cells. Thus, trex2null cells exhibit a mild (but significant) increase in DSBs and fragments while Trex2H188A cells exhibit a much larger increase.

Table 1.

Metaphase Spread Summary

MPS DSB % DSB 1 RbT 2 RbT total RbT % RbT
1. AB2.2 400 4 1.0 1 0 1 0.25
2. trex2null(2E1) 70 3 4.0 12 0 12 17.14
3. trex2null(2F7) 70 3 4.0 9 1 11 15.71
4. trex2hTX2(cl-1) 69 1 1.4 0 0 0 0
5. trex2hTX2(cl-2) 4 0 0 0 0 0 0
6. trex2R167A(cl-1) 76 1 1.3 0 0 0 0
7. trex2R167A(cl-2) 69 1 1.4 1 0 0 0
8. trex2H188A(cl-1) 84 12 14.3 1 0 0 0
9. trex2H188A(cl-2) 99 26 26.3 0 0 0 0

MPS: the total number of metaphase spreads observed.

1RbT: the number of metaphase spreads with one RbT.

2RbT: the number of metaphase spreads with two RbTs.

Fig. 2.

Fig. 2

Trex2H188A cells exhibit chromosome DSBs and fragments. Chromosomes are stained with DAPI (blue), a telomeric probe (green) and a MSR probe from the pericentromere (red). In mice the short arms are very small causing the telomeric and MSR probes to overlap resulting in a bleached yellow dot. (A) Metaphase spread with a chromosome DSB/fragment (arrow). (B) Enlargement of the chromosome with a DSB. Note the DSB occurs at the junction of the long arms and the pericentromere such that some of the pericentromere is still attached to the long arms. (C) Graph that shows the Trex2H188A cells exhibit a greater number of chromosome DSBs compared to AB2.2, trex2null, Trex2hTX2 and Trex2R167A cells. The numbers for both clones shown in Table 1 is averaged.

These data suggest TREX2 suppresses spontaneous chromosomal DSBs while TREX2H188A induces chromosomal DSBs in a dominate-negative fashion. These observations suggest that TREX2 participates in a basic metabolic process to maintain chromosomes (in particular the pericentromere) and that TREX2-deletion leads to a low level of DSBs. Furthermore, exonuclease defective TREX2 may interfere with this metabolic process leading to a much larger increase in DSBs as compared to a simple deletion. Even though H188A causes a partial defect in DNA binding this dominant negative effect appears to be restricted to defective catalytic activity since R167A reduces DNA binding but does not increase DSBs. This observation also suggests that fully efficient DNA binding is not critical for suppressing these DSBs. At present, understanding this metabolic process is purely guesswork, but a tantalizing possibility is that TREX2 resolves anomalous DNA structures that may arise in highly repetitive DNA and failure to do so may result in broken chromosomes. Since trex2null cells show elevated levels of RbTs [12], it would be interesting if the defective TREX2 variants can rescue this phenotype.

These metaphase spreads were also observed for RbTs. Previously we showed that about 16% of trex2null metaphase spreads exhibited RbTs compared to about 0.25% of control spreads. We found that knock-in of the short human TREX2 isoform by gene targeting rescued this phenotype [12]. We reproduced these data here, showing that Cre-mediated knock-in of the same cDNA also rescued this phenotype since no RbTs were observed out of a total of 73 metaphase spreads (Table 1). Interestingly we also find that Trex2H188A and Trex2R167A cells do not show RbTs: 0 RbTs out of 183 total metaphase spreads and 0 RbTs out of 145 total metaphase spreads, respectively. Thus, human TREX2 wild type (p>0.001, Fisher’s exact test), H188A (p>0.001) and R167A (p>0.001) rescue the RbT phenotype showing that exonuclease activity and DNA binding are not important for suppressing this phenotype. This is surprising since there are no other known biochemical activities for TREX2 and suggests that TREX2 possesses other activities important for chromosomal maintenance. These data also suggest that the elevated DSBs observed in trex2null and Trex2H188A cells do not induce RbTs suggesting RbTs are not the result of repairing these breaks through an aberrant pathway.

Here we evaluate the TREX2 exonuclease and DNA binding domains in mouse ES cells. By Cre-mediated knock-in, we introduced adjacent to the mouse Trex2 promoter wild type human TREX2 cDNA or human TREX2 cDNA mutated in either the exonuclease domain (H188A) or the DNA binding domain (R167A). We find that trex2null cells display a mild increase in chromosomal DSBs while Trex2H188A cells exhibit a much higher level of these DSBs, usually in or near the pericentromere. These observations suggest TREX2 participates in a metabolic activity to maintain the pericentromere and perhaps other chromosomal regions. We also show that the exonuclease and DNA binding domains are not important for suppressing RbTs. Thus, TREX2 must possess other biochemical functions that suppress RbTs. These data suggest that TREX2 is important for maintaining chromosomal stability through multiple mechanisms.

Acknowledgments

We are grateful to Mr. Sergio Lopez for statistical analysis (The Department of Epidemiology and Biostatistics, The University of Texas Health Science Center at San Antonio). This work was supported by 3P30 CA054174-16S2, UO1 ES11044, 1 RO1 CA123203-01A1 to PH and T32 CA86800-03 to LCD.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Lindahl T, Gally JA, Edelman GM. Properties of deoxyribonuclease 3 from mammalian tissues. J Biol Chem. 1969;244:5014–5019. [PubMed] [Google Scholar]
  • 2.Lindahl T. Excision of pyrimidine dimers from ultraviolet-irradiated DNA by exonucleases from mammalian cells. Eur J Biochem. 1971;18:407–414. doi: 10.1111/j.1432-1033.1971.tb01257.x. [DOI] [PubMed] [Google Scholar]
  • 3.Hoss M, Robins P, Naven TJ, Pappin DJ, Sgouros J, Lindahl T. A human DNA editing enzyme homologous to the Escherichia coli DnaQ/MutD protein. Embo J. 1999;18:3868–3875. doi: 10.1093/emboj/18.13.3868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Mazur DJ, Perrino FW. Identification and expression of the TREX1 and TREX2 cDNA sequences encoding mammalian 3′-->5′ exonucleases. J Biol Chem. 1999;274:19655–19660. doi: 10.1074/jbc.274.28.19655. [DOI] [PubMed] [Google Scholar]
  • 5.Mazur DJ, Perrino FW. Excision of 3′ termini by the Trex1 and TREX2 3′-->5′ exonucleases. Characterization of the recombinant proteins. J Biol Chem. 2001;276:17022–17029. doi: 10.1074/jbc.M100623200. [DOI] [PubMed] [Google Scholar]
  • 6.Morita M, Stamp G, Robins P, Dulic A, Rosewell I, Hrivnak G, Daly G, Lindahl T, Barnes DE. Gene-targeted mice lacking the Trex1 (DNase III) 3′-->5′ DNA exonuclease develop inflammatory myocarditis. Mol Cell Biol. 2004;24:6719–6727. doi: 10.1128/MCB.24.15.6719-6727.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Yang YG, Lindahl T, Barnes DE. Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. Cell. 2007;131:873–886. doi: 10.1016/j.cell.2007.10.017. [DOI] [PubMed] [Google Scholar]
  • 8.Stetson DB, Ko JS, Heidmann T, Medzhitov R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell. 2008;134:587–598. doi: 10.1016/j.cell.2008.06.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kavanagh D, Spitzer D, Kothari PH, Shaikh A, Liszewski MK, Richards A, Atkinson JP. New roles for the major human 3′-5′ exonuclease TREX1 in human disease. Cell Cycle. 2008;7:1718–1725. doi: 10.4161/cc.7.12.6162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.O’Driscoll M. TREX1 DNA exonuclease deficiency, accumulation of single stranded DNA and complex human genetic disorders. DNA Repair (Amst) 2008;7:997–1003. doi: 10.1016/j.dnarep.2008.02.010. [DOI] [PubMed] [Google Scholar]
  • 11.Chowdhury D, Beresford PJ, Zhu P, Zhang D, Sung JS, Demple B, Perrino FW, Lieberman J. The Exonuclease TREX1 Is in the SET Complex and Acts in Concert with NM23-H1 to Degrade DNA during Granzyme A-Mediated Cell Death. Mol Cell. 2006;23:133–142. doi: 10.1016/j.molcel.2006.06.005. [DOI] [PubMed] [Google Scholar]
  • 12.Chen MJ, Dumitrache LC, Wangsa D, Ma SM, Padilla-Nash H, Ried T, Hasty P. Cisplatin Depletes TREX2 and Causes Robertsonian Translocations as Seen in TREX2 Knockout Cells. Cancer Res. 2007;67:9077–9083. doi: 10.1158/0008-5472.CAN-07-1146. [DOI] [PubMed] [Google Scholar]
  • 13.Slijepcevic P. Telomeres and mechanisms of Robertsonian fusion. Chromosoma. 1998;107:136–140. doi: 10.1007/s004120050289. [DOI] [PubMed] [Google Scholar]
  • 14.Garagna S, Marziliano N, Zuccotti M, Searle JB, Capanna E, Redi CA. Pericentromeric organization at the fusion point of mouse Robertsonian translocation chromosomes. Proc Natl Acad Sci U S A. 2001;98:171–175. doi: 10.1073/pnas.98.1.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Hauffe HC, Searle JB. Chromosomal heterozygosity and fertility in house mice (Mus musculus domesticus) from Northern Italy. Genetics. 1998;150:1143–1154. doi: 10.1093/genetics/150.3.1143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Pialek J, Hauffe HC, Rodriguez-Clark KM, Searle JB. Raciation and speciation in house mice from the Alps: the role of chromosomes. Mol Ecol. 2001;10:613–625. doi: 10.1046/j.1365-294x.2001.01209.x. [DOI] [PubMed] [Google Scholar]
  • 17.Multani AS, Kacker RK, Pathak S. Are Robertsonian translocations rare in cancers? Cancer Genet Cytogenet. 1997;93:179–180. doi: 10.1016/s0165-4608(96)00182-3. [DOI] [PubMed] [Google Scholar]
  • 18.Cammarata M, Corsello G, Marino M, Morabito M, Pecoraro MR, Piccione M, Giuffre L. Genetic factors of recurrent abortions. Acta Eur Fertil. 1989;20:367–370. [PubMed] [Google Scholar]
  • 19.Fraccaro M. Chromosome abnormalities and gamete production in man. Differentiation. 1983;23(Suppl):S40–43. doi: 10.1007/978-3-642-69150-8_7. [DOI] [PubMed] [Google Scholar]
  • 20.Perrino FW, Harvey S, McMillin S, Hollis T. The human TREX2 3′-> 5′-exonuclease structure suggests a mechanism for efficient nonprocessive DNA catalysis. J Biol Chem. 2005;280:15212–15218. doi: 10.1074/jbc.M500108200. [DOI] [PubMed] [Google Scholar]
  • 21.Chen MJ, Ma SM, Dumitrache LC, Hasty P. Biochemical and cellular characteristics of the 3′-> 5′ exonuclease TREX2. Nucleic Acids Res. 2007;35:2682–2694. doi: 10.1093/nar/gkm151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Perrino FW, de Silva U, Harvey S, Pryor EE, Jr, Cole DW, Hollis T. Cooperative DNA Binding and Communication across the Dimer Interface in the TREX2 3′-> 5′-Exonuclease. J Biol Chem. 2008;283:21441–21452. doi: 10.1074/jbc.M803629200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Kim T-M, Choi YJKJH, Hasty P. High througput knock-in coupling gene targeting with the HPRT minigene and Cre-mediated recombination. Genesis. 2008 doi: 10.1002/dvg.20439. in press. [DOI] [PubMed] [Google Scholar]
  • 24.Ramirez-Solis R, Rivera-Perez J, Wallace JD, Wims M, Zheng H, Bradley A. Genomic DNA microextraction: a method to screen numerous samples. Anal Biochem. 1992;201:331–335. doi: 10.1016/0003-2697(92)90347-a. [DOI] [PubMed] [Google Scholar]
  • 25.Reid LH, Gregg RG, Smithies O, Koller BH. Regulatory elements in the introns of the human HPRT gene are necessary for its expression in embryonic stem cells. Proc Natl Acad Sci U S A. 1990;87:4299–4303. doi: 10.1073/pnas.87.11.4299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Araki K, Araki M, Yamamura K. Targeted integration of DNA using mutant lox sites in embryonic stem cells. Nucleic Acids Res. 1997;25:868–872. doi: 10.1093/nar/25.4.868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Holcomb VB, Kim TM, Dumitrache LC, Ma SM, Chen MJ, Hasty P. HPRT minigene generates chimeric transcripts as a by-product of gene targeting. Genesis. 2007;45:275–281. doi: 10.1002/dvg.20300. [DOI] [PubMed] [Google Scholar]
  • 28.Guenatri M, Bailly D, Maison C, Almouzni G. Mouse centric and pericentric satellite repeats form distinct functional heterochromatin. J Cell Biol. 2004;166:493–505. doi: 10.1083/jcb.200403109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Adra CN, Boer PH, McBurney MW. Cloning and expression of the mouse pgk-1 gene and the nucleotide sequence of its promoter. Gene. 1987;60:65–74. doi: 10.1016/0378-1119(87)90214-9. [DOI] [PubMed] [Google Scholar]

RESOURCES